Delivery Order SPE2DB22D1202-SPE2DB25FVMV9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Zymfentra 120 mg/mL pens in a two-pack quantity, with a ceiling value of $1,503.56 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of October 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's...
- On September 22, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,014.24 to AmerisourceBergen Drug Corp for the supply of Zymfentra 120 mg/ml pens in a two-pack configuration. This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a non-competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $1,503.56 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen (2-pack) with a completion date of September 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was issued on September 9, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen (2-pack) pharmaceutical supplies. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under a larger indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen (2-pack) on September 9, 2025, with completion scheduled for September 30, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $4,212.90 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen (2-pack units) on September 8, 2025, with an ultimate completion date of September 29, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award through open procurement. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies valued at $1,503.56 on August 27, 2025. The order encompasses Zymfentra 120 mg/ml pens in a 2-pack quantity, with an ultimate completion date of September 18, 2025. This non-set-aside contract utilizes firm fixed price pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is structured as a child contract...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $3,007.12 for Zymfentra 120 mg/ml pens (2-pack quantity) on August 1, 2025, with an ultimate completion date of August 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance location. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Zymfentra 120 mg/ml Pen (2-pack) units at a ceiling value of $1,503.56. This firm fixed price delivery order, with an ultimate completion date of October 7, 2025, represents a non-competitive, non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract is classified as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,007.12 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, with an ultimate completion date of October 7, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award under the company's existing indefinite delivery contract vehicle with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVMV9Delivery Order
The Defense Logistics Agency awarded a $1,503.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen (2-pack) pharmaceutical supplies on September 29, 2025, with completion targeted for October 21, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with particular focus on supporting military and veteran healthcare systems. The delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply portfolio managed through the DLA Medical Supply Chain, which encompasses brand-name and generic medications, vaccines, specialty drugs, and related medical supplies across multiple therapeutic domains. As a major pharmaceutical wholesaler with demonstrated federal procurement capabilities, AmerisourceBergen has consistently secured competitive awards for medical supply deliveries ranging from small transactions to substantial orders, positioning the company to fulfill diverse federal healthcare requirements. The company is also positioned as a potential contractor for the planned Pharmaceutical Prime Vendor Global Program Generation V contracts, which DLA Troop Support intends to award to multiple vendors for regional pharmaceutical support globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/29/25 |